tiprankstipranks

Charles Sheedy Insider Profile

4 Followers
Charles Sheedy, Ten Percent Owner at Acer Therapeutics, holds 11.32M shares in Nuo Therapeutics (Ticker: AURX), holds 752.35K shares in Acer Therapeutics (Ticker: ACER). Most recently, Charles Sheedy Bought ― shares of Nuo Therapeutics on May 21, 2024 for an estimated value of 75.00K.
tipranks
Charles Sheedy

Charles Sheedy
Acer Therapeutics (ACER)
Ten Percent Owner

Ranked #2,599 out of 97,944 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

+112.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
A breakdown of Charles Sheedy's holdings

Insider Roles

Nuo Therapeutics
(AURX)
Ten Percent Owner
Roles that Charles Sheedy holds in companies

Most Profitable Insider Trade

Stock:
Nuo Therapeutics
(AURX)
Rating:Informative Buy
Date:May 02, 2022 - May 02, 2023
Return:+800.00%
The most profitable trade made by Charles Sheedy

Charles Sheedy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ACER
Acer Therapeutics
Jul 23, 2009
Informative Buy
$496.55K
Nuo Therapeutics
May 21, 2024
Ten Percent Owner
Informative Buy
75.00K
$4.27M
List of latest transactions for each holding click on a transaction to see Charles Sheedy's performance on stock

Charles Sheedy insider profile FAQ

What is the percentage of profitable transactions made by Charles Sheedy?
The percentage of profitable transactions made by Charles Sheedy is 20%.
    What is the average return per transaction made by Charles Sheedy?
    The average return per transaction made by Charles Sheedy is 112.70%.
      What stocks does Charles Sheedy hold?
      Charles Sheedy holds: ACER, AURX stocks.
        What was Charles Sheedy’s latest transaction?
        Charles Sheedy latest transaction was an Informative Buy of $75.00K.
          What was Charles Sheedy's most profitable transaction?
          Charles Sheedy’s most profitable transaction was an Informative Buy of AURX stock on May 2, 2022. The return on the trade was 800.00%.
            What is Charles Sheedy's role in Acer Therapeutics?
            Charles Sheedy's role in Acer Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.